Hannah Rush

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

N.W. Clarke, Amin Ali, Fiona C. Ingleby et al. · Annals of Oncology · 2019 · 389 citations · Full text

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial

Chris Parker, Nicholas D. James, Chris Brawley et al. · PLoS Medicine · 2022 · 112 citations · Full text

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

Gerhardt Attard, Laura Murphy, Noel W. Clarke et al. · The Lancet Oncology · 2023 · 85 citations · Full text

Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)

Nicholas D. James, Noel W. Clarke, Adrian Cook et al. · International Journal of Cancer · 2022 · 72 citations · Full text

Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience

Nalinie Joharatnam‐Hogan, Daniel Hochhauser, Kai‐Keen Shiu et al. · Therapeutic Advances in Medical Oncology · 2020 · 37 citations · Full text